中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2011年
2期
208-210
,共3页
周金萍%蔡璐%陈公锦%王淼%刘冬炎%金原野%马连军%袁飞
週金萍%蔡璐%陳公錦%王淼%劉鼕炎%金原野%馬連軍%袁飛
주금평%채로%진공금%왕묘%류동염%금원야%마련군%원비
右美托咪啶%麻醉,局部%支气管肺泡灌洗
右美託咪啶%痳醉,跼部%支氣管肺泡灌洗
우미탁미정%마취,국부%지기관폐포관세
Dexmedetomidine%Anesthesia,local%Bronchoalveolar lavage
目的 探讨右美托咪啶辅助表面麻醉用于患者支气管肺泡灌洗术的效果.方法 拟行支气管肺泡灌洗术的ICU患者24例,ASA分级Ⅱ或Ⅲ级,体重50~80 kg,年龄24~64岁,采用随机数字表法,将患者随机分为2组(n=12),A组术前30 min静脉注射0.9%生理盐水5 ml,术前5 min经气管导管或气管套管内注入2%利多卡因5~10 ml,随后按需每15~30 min经纤维支气管镜追加2%利多卡因5 ml,总量控制在20 ml以内;B组术前30 min缓慢静脉注射右美托咪啶0.5~1.0 μg/kg,随后以0.1~0.5 μg·kg-1·h-1速率维持,表面麻醉方法同A组.记录灌洗时间、不良反应及心血管不良事件的发生情况.于灌洗前20 min(T1)、灌洗开始后20 min(T2)、灌洗结束后20 min(T3)时采集血样,测定血浆儿茶酚胺浓度和血清皮质醇浓度.结果 与A组比较,B组血清皮质醇浓度、血浆儿茶酚胺浓度降低、不良反应及心血管不良事件发生率降低,操作时间缩短(P<0.05).与T1时比较,A组T2,3时血清皮质醇及血浆儿茶酚胺浓度升高,B组T2,3时血清皮质醇及血浆儿茶酚胺浓度降低(P<0.05).结论 右美托咪啶辅助表面麻醉可安全有效地用于患者支气管肺泡灌洗术.
目的 探討右美託咪啶輔助錶麵痳醉用于患者支氣管肺泡灌洗術的效果.方法 擬行支氣管肺泡灌洗術的ICU患者24例,ASA分級Ⅱ或Ⅲ級,體重50~80 kg,年齡24~64歲,採用隨機數字錶法,將患者隨機分為2組(n=12),A組術前30 min靜脈註射0.9%生理鹽水5 ml,術前5 min經氣管導管或氣管套管內註入2%利多卡因5~10 ml,隨後按需每15~30 min經纖維支氣管鏡追加2%利多卡因5 ml,總量控製在20 ml以內;B組術前30 min緩慢靜脈註射右美託咪啶0.5~1.0 μg/kg,隨後以0.1~0.5 μg·kg-1·h-1速率維持,錶麵痳醉方法同A組.記錄灌洗時間、不良反應及心血管不良事件的髮生情況.于灌洗前20 min(T1)、灌洗開始後20 min(T2)、灌洗結束後20 min(T3)時採集血樣,測定血漿兒茶酚胺濃度和血清皮質醇濃度.結果 與A組比較,B組血清皮質醇濃度、血漿兒茶酚胺濃度降低、不良反應及心血管不良事件髮生率降低,操作時間縮短(P<0.05).與T1時比較,A組T2,3時血清皮質醇及血漿兒茶酚胺濃度升高,B組T2,3時血清皮質醇及血漿兒茶酚胺濃度降低(P<0.05).結論 右美託咪啶輔助錶麵痳醉可安全有效地用于患者支氣管肺泡灌洗術.
목적 탐토우미탁미정보조표면마취용우환자지기관폐포관세술적효과.방법 의행지기관폐포관세술적ICU환자24례,ASA분급Ⅱ혹Ⅲ급,체중50~80 kg,년령24~64세,채용수궤수자표법,장환자수궤분위2조(n=12),A조술전30 min정맥주사0.9%생리염수5 ml,술전5 min경기관도관혹기관투관내주입2%리다잡인5~10 ml,수후안수매15~30 min경섬유지기관경추가2%리다잡인5 ml,총량공제재20 ml이내;B조술전30 min완만정맥주사우미탁미정0.5~1.0 μg/kg,수후이0.1~0.5 μg·kg-1·h-1속솔유지,표면마취방법동A조.기록관세시간、불량반응급심혈관불량사건적발생정황.우관세전20 min(T1)、관세개시후20 min(T2)、관세결속후20 min(T3)시채집혈양,측정혈장인다분알농도화혈청피질순농도.결과 여A조비교,B조혈청피질순농도、혈장인다분알농도강저、불량반응급심혈관불량사건발생솔강저,조작시간축단(P<0.05).여T1시비교,A조T2,3시혈청피질순급혈장인다분알농도승고,B조T2,3시혈청피질순급혈장인다분알농도강저(P<0.05).결론 우미탁미정보조표면마취가안전유효지용우환자지기관폐포관세술.
Objective To investigate the efficacy of dexmedetomidine-assisted topical anesthesia in patients undergoing bronchoalveolar lavage ( BAL). Methods Twenty-four ASA Ⅱ or Ⅲ patients in ICU, aged 24-64 yr, weighing 50-80 kg, scheduled for BAL, were randomly divided into 2 groups ( n = 12 each) : topical anesthesia group (group A) , topical anesthesia + dexmedetomidine group (group B) . In group A, 0.9% normal saline 5 ml was injected intravenously 30 min before operation, 2% lidocaine 5-10 ml was given via a tracheal tube or cannula 5 min before operation and then an increment of 2% lidocaine 5 ml was given using fibreoptic bronchoscope every 15-30 min as required (the total amount was within 20 ml) . In group B, dexmedetomidine 0.5-1.0 μg/kg was injected (time of injection≥ 10 min) followed by infusion at 0.1-0.5 μg·kg-1 ·h-1 and the topical anesthesia was performed as the method described in group A. The time of lavage, adverse reactions and adverse cardiovascular events were recorded. Blood samples were taken 20 min before lavage, 20 min after the start of lavage and 20 min after the end of lavage (T1-3 ) for determination of the concentrations of plasma catecholamine and serum cortisol. Results The incidences of adverse reactions and adverse cardiovascular events were significantly lower and the operation time was significantly shorter in group B than in group A ( P < 0.05). The concentrations of plasma catecholamine and serum cortisol were significantly higher at T2,3 in group A, while lower at T2,3 in group B than at T1 ( P < 0.05) . The concentrations of plasma catecholamine and serum cortisol were significantly lower in group B than in group A ( P < 0.05). Conclusion Dexmedetomidine-assisted topical anesthesia can be used safely and effectively in BAL.